CEO Times

Hayatt Med-Tech Develops the World’s First Fully-Automated, Non-Invasive and Multi-Parameter COVID-19 Rapid Screening Device

Hayatt Med-Tech, an innovative and disruptive startup in the medical technology industry, today announced the development of Hayatt Thermox-D, a patent-pending fully-automated state-of-the-art device capable of performing rapid multi-parameter COVID-19 screening. This groundbreaking device provides communities and businesses a novel solution to mitigate the risk of infectious disease transmission, allowing them to more safely resume in-person activities and combat the progression of this devastating global pandemic.

BUSINESS RECORDER

Hayatt Med-Tech Develops World’s First Fully-Automated, Non-Invasive and Multi-Parameter COVID-19 Rapid Screening Device

NEW YORK CITY, NEW YORK, UNITED STATES, May 28, 2021 /EINPresswire.com/ -- Hayatt Med-Tech, an innovative and disruptive startup in the medical technology industry, today announced the development of Hayatt Thermox-D, a patent-pending fully-automated state-of-the-art device capable of performing rapid multi-parameter COVID-19 screening. This groundbreaking device provides communities and businesses a novel solution to mitigate the risk of infectious disease transmission, allowing them to more safely resume in-person activities and combat the progression of this devastating global pandemic.

EINPRESSWIRE

Hayatt Med-Tech develops fully-automated Covid-19 Rapid Screening Device

NEW YORK CITY: Hayatt Med-Tech, an innovative startup in the medical technology industry, Friday announced the development of Hayatt Thermox-D, a patent pending fully-automated state-of-the-art device capable of performing rapid multi-parameter Covid-19 screening.

MED-TECH INNOVATION NEWS

Start-up develops automated COVID-19 screening device

Start-up Hayatt Med-Tech has announced the development of Hayatt Thermox-D, a patent-pending fully-automated device capable of performing rapid multi-parameter COVID-19 screening.